{
  "url": "https://openlegislation.uk/prescription-only-medicines-human-use-amendment-order-2003/article-4",
  "json_url": "https://openlegislation.uk/prescription-only-medicines-human-use-amendment-order-2003/article-4.json",
  "legislation": "uksi/2003/696",
  "legislation_title": "The Prescription Only Medicines (Human Use) Amendment Order 2003",
  "legislation_url": "https://openlegislation.uk/prescription-only-medicines-human-use-amendment-order-2003",
  "path": "article/4",
  "kind": "article",
  "number": "4",
  "heading": "Amendment of article 3 of the principal Order",
  "text": "In article 3 of the principal Order (medicinal products on prescription only), after paragraph (f) add the following paragraph—\n“(g) medicinal products in respect of which a marketing authorization has been granted consisting of or containing aloxiprin, aspirin or paracetamol in the form of non-effervescent tablets or capsules which in the marketing authorization are classified as being pharmacy only or general sale list medicines.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2003/696/article/4",
    "retrieved_at": "2026-10-29T06:28:56.354251+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}